Similar articles

• Animal vaccination studies with Mycobacterium leprae.

  Shepard CC. Shepard CC. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):519-23. Int J Lepr Other Mycobact Dis. 1983. PMID: 6368416 No abstract available.
• Rationales for vaccines against leprosy.

  Bloom BR. Bloom BR. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):505-9. Int J Lepr Other Mycobact Dis. 1983. PMID: 6368414 Clinical Trial. No abstract available.
• Collection method for Mycobacterium leprae from infected armadillo liver.

  Mori T, Miyata Y, Yoneda K, Ito T. Mori T, et al. Int J Lepr Other Mycobact Dis. 1984 Mar;52(1):41-3. Int J Lepr Other Mycobact Dis. 1984. PMID: 6368427
• [The importance of the protein antigens of Mycobacterium leprae. Their potential use for the development of a vaccine against leprosy].

  Vega-López F, Macotela-Ruiz E. Vega-López F, et al. Gac Med Mex. 1991 Jan-Feb;127(1):31-9. Gac Med Mex. 1991. PMID: 1959737 Review. Spanish.
• Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

  Gormus BJ, Meyers WM. Gormus BJ, et al. Expert Rev Vaccines. 2003 Dec;2(6):791-804. doi: 10.1586/14760584.2.6.791. Expert Rev Vaccines. 2003. PMID: 14711362 Review.